Integer Holdings (ITGR) revenue breakdown
By segment, Medical is the largest at 97% of fiscal 2023 revenue, growing 6% a year over 7 years.
By product, Cardio And Vascular is the largest at 60% of fiscal 2025 revenue, growing 17% a year over 3 years.
Revenue by segment
Fiscal years, as Integer Holdings reports them in its 10-K filings; fiscal 2023 total $1.6B.
| Segments | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | Share |
|---|---|---|---|---|---|---|---|---|---|
| Medical | $1.0B | $1.1B | $1.2B | $1.2B | $1.0B | $1.2B | $1.3B | $1.6B | 97% |
| Non-Medical | $42M | $57M | $53M | $58M | $35M | $38M | $47M | $43M | 3% |
Revenue by product
Fiscal years, as Integer Holdings reports them in its 10-K filings; fiscal 2025 total $1.9B.
| Products | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|
| Cardio And Vascular | $699M | $836M | $950M | $1.1B | 60% |
| Cardiac Rhythm Management & Neuromodulation | $534M | $613M | $661M | $669M | 36% |
| Other Markets | $98M | $106M | $106M | $78M | 4% |
Revenue by region
Fiscal years, as Integer Holdings reports them in its 10-K filings; fiscal 2025 total $1.9B.
| Regions | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| U.S. | $626M | $662M | $687M | $698M | $597M | $672M | $733M | $873M | $939M | $980M | 53% |
| Rest of world | $234M | $278M | $319M | $341M | $322M | $372M | $408M | $384M | $432M | $470M | 25% |
| Costa Rica | $54M | $55M | $62M | $64M | $59M | $67M | $76M | $108M | $125M | $174M | 9% |
| Puerto Rico | $162M | $140M | $146M | $155M | $96M | $110M | $114M | $121M | $137M | $131M | 7% |
| Ireland | — | — | — | — | — | — | — | $69M | $84M | $99M | 5% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for ITGR.
Open ITGR in InvestinglyQuestions
Where does Integer Holdings make its money?
In fiscal 2023, by segment: Medical $1.6B, Non-Medical $43M.
From Integer Holdings's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.